1. Purpose The Fund to support the solvency of strategic companies (“Fund”) is aimed at offsetting the impact of the health emergency on solvent companies’ balance sheets, when these are considered strategic for the national or regional productive and economic fabric, among other reasons, on account of their significant social and economic impact, their role in terms of security, public health, infrastructure, communications or their contribution to the smooth operation of the markets, in cases…
Latest Posts
- Spain: Main Aspects of the Agreement Setting Up the Functioning of the Fund to Support Strategic Companies’ Solvency
- Singapore: Key Changes to Singapore Insolvency Framework
- Switzerland: Masterclass in Swiss efficiency – spotlight on Switzerland’s Government-backed COVID-19 loan programme for SMEs
- Spain: Application of the Rebus Sic Stantibus Doctrine to Suspend Payment Obligations and Financial Covenants Under a Refinancing Agreement
- United Kingdom: Corporate Insolvency and Governance Act 2020 becomes law
- United States: Liquidity Enhancements – Andrew Sagor interviewed for Debtwire Podcast
- UK: Opportunities in distressed M&A
- Australia: High standards – challenging a DOCA that compromises a litigation claim
Recent
The Insolvency, Restructuring and Dissolution Act (the IRDA) commenced on 30 July 2020. The IRDA is an omnibus…
This article first appeared in the July/August issue of Butterworths Journal of International Banking and Financial Law. This…
Ruling 155/2020, of 30 April, issued by the Court of First Instance No. 60 of Madrid – Celsa…
In brief In May, we reported that the UK Government’s much anticipated reforms to UK insolvency law were…
Andrew Sagor, Co-Chair of the North America Leveraged Finance Practice, joins Debtwire senior legal analyst Rich Goldman to…
The Covid-19 pandemic is likely to give rise to a wave of distressed companies looking for buyers or…